Structure of signal peptide peptidase
Structure of signal peptide peptidase
批准号:
7329807
负责人:
Raquel L Lieberman
金额:
$0.35万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2008-01-01
关键词:
Active SitesAffectAlzheimer&aposs DiseaseAmyloid beta-Protein PrecursorArchaeaAspartic EndopeptidasesBinding SitesBiochemistryBiological ProcessCleaved cellComputer SimulationDevelopmentDrug DesignEndopeptidasesEnzymesEscherichia coliExhibitsFamilyGoalsHomologous GeneHumanImmune responseIndividualKnowledgeLifeLinkMissense MutationMolecularMolecular ProbesMultiprotein ComplexesMutationOrthologous GenePatientsPeptide HydrolasesPeptide Signal SequencesPeptidesPharmaceutical PreparationsPreclinical Drug EvaluationPresenile Alzheimer DementiaProcessProteolysisScreening procedureSignal TransductionSilicon DioxideSiteStructural ModelsStructureanalogbasedrug developmentinhibitor/antagonistinsightmemberpeptidomimeticspresenilinsecretasesignal peptidasesignal peptide peptidase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The multiprotein complex y-secretase proteolytically cleaves the intramembrane region of amyloid precursor
protein (APP), which in turn forms the plaques found in Alzheimer's disease (AD) patients. The catalytic
component of Y-secretase is the intramembrane aspartyl protease (IAP) called presenilin. Mutations in
presenilin are directly linked to familial early-onset AD. Another known member of the IAP family is signal
peptide peptidase (SPP), which functions to further proteolyze remnant signal peptides after they have been
cleaved by signal peptidase. Knowledge of the biochemistry and function of individual SPPs are only
beginning to be elucidated, and homologues are found in all kingdoms of life. Presenilin and SPP exhibit
significant sequence similarity, strongly suggesting they share structural and catalytic features. Thus, a
molecular understanding of the more tractable SPP will likely impact drug design for presenilin and y-
secretase. The goal of this proposal is to express, characterize, and solve the crystal structure of an
extremophilic bacterial SPP ortholog by itself, with a transition-state analog inhibitor and with a substrate
mimic. In addition, drug candidates will be screened in silico. This first structure of an intramembrane
protease will provide critical insight into the biochemistry of intramembrane proteolysis and enable structure-
based AD drug development and screening.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4061/2011/973231
发表时间:
2011
期刊:
Enzyme research
影响因子:
--
作者:
[Lieberman RL]
通讯作者:
Lieberman RL
Molecular basis of 1-deoxygalactonojirimycin arylthiourea binding to human -galactosidase: Pharmacological chaperoning efficacy on Fabry disease mutants.
1-脱氧半乳糖野尻霉素芳基硫脲与人结合的分子基础
DOI:
10.1021/cb500143h
发表时间:
2014
期刊:
ACS Chem Biol
影响因子:
--
作者:
[Togawa T., Takada M., Aizawa Y., Tsukimura T., Chiba Y., Sakuraba H., 小松誠一郎,森谷昇太,車暁芳,河野範男,宮澤啓介, Akiko Okuda, 森谷昇太,小松誠一郎,山﨑佳穗,車暁芳,宮澤啓介, 奥田明子, Yu Y,]
通讯作者:
Yu Y,
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:10723134
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin : glaucoma as a protein misfolding disease DEIA Supplement
-
批准号:10789112
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:8616070
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:10357759
-
项目类别:
-
资助金额:$38.89万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:9239535
-
项目类别:
-
资助金额:$35.54万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:10052403
-
项目类别:
-
资助金额:$44.05万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:8232001
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Request for Supplement to Promote Diversity in Health Related Research
-
批准号:10359309
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
CHARACTERIZATION OF PURIFIED MYOCILIN: INSIGHT INTO GLAUCOMA
-
批准号:10622963
-
项目类别:
-
资助金额:$7.67万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:8420505
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:10614924
-
项目类别:
-
资助金额:$40.1万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:8022511
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:8812847
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
-
批准号:10723129
-
项目类别:
-
资助金额:$7.67万
-
财政年份:2011
-
负责人:Raquel L Lieberman
-
依托单位:
Crystal structure of signal peptide peptidase with engineered antibody fragment
-
批准号:8110472
-
项目类别:
-
资助金额:$21.31万
-
财政年份:2010
-
负责人:Raquel L Lieberman
-
依托单位:
Crystal structure of signal peptide peptidase with engineered antibody fragment
-
批准号:7976140
-
项目类别:
-
资助金额:$19.05万
-
财政年份:2010
-
负责人:Raquel L Lieberman
-
依托单位:
Structure of signal peptide peptidase
-
批准号:7056429
-
项目类别:
-
资助金额:$4.4万
-
财政年份:2005
-
负责人:Raquel L Lieberman
-
依托单位:
Structure of signal peptide peptidase
-
批准号:7204158
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2005
-
负责人:Raquel L Lieberman
-
依托单位:
海外基金